AtaiBeckley (ATAI) Net Cash Flow (2020 - 2026)
AtaiBeckley's (ATAI) quarterly Net Cash Flow came in at -$31.1 million in Q3 2025, down 398.95% year-on-year from $10.4 million in Q3 2024, and down 1001.36% quarter-over-quarter from $3.4 million in Q2 2025.
AtaiBeckley (ATAI) Net Cash Flow (2020 - 2026) Analysis & Trends
AtaiBeckley's Net Cash Flow history runs 2 years deep, the most recent figure standing at -$41.9 million for Q1 2026.
- In Q1 2026, Net Cash Flow fell 236.33% year-over-year to -$41.9 million; the TTM figure through Mar 2026 stood at -$11.2 million (changed N/A YoY), while the FY2025 annual figure was $57.7 million, up 422.39% from the prior year.
- Net Cash Flow came in at -$31.1 million for Q3 2025 at AtaiBeckley, down from $3.4 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $30.8 million in Q1 2025 to a low of -$41.9 million in Q1 2026.
- The 5-year median for Net Cash Flow is -$11.1 million (2024), against an average of -$3.5 million.
- Across the five-year window, Net Cash Flow sank 2426.8% in 2022 and jumped 763.91% in 2025, its largest moves.
- AtaiBeckley's Net Cash Flow stood at -$67.4 million in 2021, then surged by 172.12% to $48.6 million in 2022, then plunged by 164.26% to -$31.2 million in 2023, then soared by 43.73% to -$17.6 million in 2024, then tumbled by 76.72% to -$31.1 million in 2025.
- The last three Net Cash Flow figures came in at -$31.1 million (Q3 2025), $3.4 million (Q2 2025), and $30.8 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 664,983.53 |
| 10 | AtaiBeckley | 1.45 Bn | 1.45 Bn | - | -41.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41.92 Mn |
| Mar 31, 2026 | -41.92 Mn |
| Sep 30, 2025 | -31.07 Mn |
| Sep 30, 2025 | -31.07 Mn |
| Jun 30, 2025 | 3.45 Mn |
| Jun 30, 2025 | 3.45 Mn |
| Mar 31, 2025 | 30.75 Mn |
| Mar 31, 2025 | 30.75 Mn |
| Mar 31, 2025 | 30.75 Mn |
| Mar 31, 2025 | 30.75 Mn |
| Dec 31, 2024 | -17.58 Mn |
| Dec 31, 2024 | -17.58 Mn |
| Sep 30, 2024 | 10.39 Mn |
| Sep 30, 2024 | 10.39 Mn |
| Jun 30, 2024 | 399,000.00 |
| Jun 30, 2024 | 399,000.00 |
| Mar 31, 2024 | -11.10 Mn |
| Mar 31, 2024 | -11.10 Mn |
| Dec 31, 2023 | -31.25 Mn |
| Dec 31, 2023 | -31.25 Mn |